hemopexin
Biologicalexperimental
Hemopexin, also known as beta-1B-glycoprotein, is a glycoprotein that in humans is encoded by the HPX gene and belongs to the hemopexin family of proteins. Hemopexin is the plasma protein with the highest binding affinity for heme. — Wikipedia
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Mar 31, 2020 (NCT04285827)
Timeline
Indications
Studied for
Mechanism of action
- HemeINHIBITOR
inhibitor - heme
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaHemopexin ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06699849 | Phase 2/Phase 3 (Phase 3) | Feb 10, 2025 | CSL Behring |
| NCT04285827 | Phase 1 | Mar 31, 2020 | CSL Behring |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CSL Behring | For profit | 2 | 2 | 2 | 2020 |
1 organizations
Page 1 / 1